Previous Webinars

Test Webinar Summary

We will discuss the many questions that persist due to complicated administration of CAR-T therapy

The CMS released of the final 2020 Medicare Physician Fee Schedule and the Quality Payment Program regulations on November 1.

This webinar will review the applications of this technology in small neurosurgical intraoperative specimens with quick, on-site interpretation, as well as discuss other potential applications.

The CAP will offer a webinar where CAP experts will review regulatory changes that will impact payment for services and pathologists’ participation in MIPS.

This webinar will outline different ex vivo imaging technologies for use in the Anatomic Pathology laboratory while still meeting CAP Anatomic Pathology checklist requirements.

Congratulations, you've finished training and secured employment as a pathologist, or maybe you're changing labs in hopes of a better fit. In any case, you're excited about your first day, but how do you make the most of it and where do you begin as the new pathologist in the practice? Angie Foster, MD, FCAP and Lauren King, MD, FCAP will share tips they learned from their first days on the job and provide insights to your questions during this 30-minute interactive online panel discussion.

During this 30 minute on-demand presentation, Emily E. Volk, MD, FCAP, reviews the new facility-based scoring options for pathologists in the 2019 Merit-based Incentive Payment System (MIPS).

During this 30 minute on-demand presentation, Diana Cardona, MD, FCAP, reviews the pathology-specific improvement activities that practices can attest to in order to maximize their 2019 Merit-based Incentive Payment System (MIPS) scores.

During this 30 minute on-demand presentation, Emily E. Volk, MD, FCAP, reviews strategies pathology practices can do in order to maximize their 2019 Merit-based Incentive Payment System (MIPS) scores.

Ex vivo tissue imaging using different types of optical imaging modalities has promising potential as the next generation of digital microscopy tools for rapid recognition of fresh tissue with minimal or no tissue preparation. The webinar will outline the different ex vivo optical imaging techniques that can be utilized for recognition of tissue in surgical pathology practice.

This webinar will discuss what the microbiome is, its molecular contributions to health and disease, and means to analyze its properties for diagnostic purposes.

During this on-demand presentation, Emily E Volk, MD, FCAP, the vice chair of the Council on Government and Professional Affairs explained the new requirements for the 2019 Quality Payment Program and what MIPS-eligible pathologists need to do in order to submit their data to maximize their bonus potential for 2019.

This webinar will introduce the concept of in vivo microscopy guided biopsy and will show how it is being used clinically and in research to increase tissue sampling diagnostic yield.

During this 30 minute on-demand presentation, Diana Cardona, MD, FCAP, chair of the CAP Economic Affairs Measures & Performance Assessment Subcommittee, reviews the 2019 quality measures available for pathologists.

To help pathologists successfully navigate the new and evolving payment models, the CAP launched a series of 30-minute webinars.

Presented by CAP advocacy leader Emily E. Volk, MD, MBA, FCAP, this webinar details what pathologists need to know before submitting their 2018 MIPS data.

While many pathology practices are not required to produce an annual report, some choose to report their accomplishments and promote their unique differentiators defining their value to administration through an annual report.

Explore the benefits of CAP accreditation to help achieve continuous compliance, best practices, and fresh approaches for your laboratory.

During this 30-minute webinar, Diana Cardona, MD, FCAP, Chair of the CAP Economic Affairs Measures & Performance Assessment Subcommittee, will review the CAP-developed quality measures available for pathologists, and the specifications for those measures. Dr. Cardona will also discuss ways to maximize performance and scoring using the CAP measures.

Compliance is a subject that can strike fear in the heart of the most stalwart pathologist—But, it doesn’t have to! Join us for a webinar on “Current Topics in Compliance” to unravel some its complexities, including the necessary elements of a robust Compliance Plan per the OIG and a discussion of some of the more risk-prone areas of pathology practice.

This webinar focuses on the final 2019 Medicare Physician Fee Schedule and Quality Payment Program regulations that were released on November 1, 2018.

Find answers to your questions about the interpretation criteria, diagnostic categories, and rationale for changes in the Updated HER2 Testing in Breast Cancer Guideline, jointly published by the American Society of Clinical Oncology (ASCO) and the CAP.

Medicare Part A contracts provide significant revenue to many practices but negotiating a good contract can be a challenge.

As part of our ongoing commitment to ensure pathologists are able to successfully participate in new and evolving payment models, the CAP is pleased to offer a comprehensive MIPS education webinar series specifically developed for pathologists, led by experts who will take a deep dive into components of the MIPS program.

As part of our ongoing commitment to ensure pathologists are able to successfully participate in new and evolving payment models, the CAP is pleased to offer a comprehensive MIPS education webinar series specifically developed for pathologists, led by experts who will take a deep dive into components of the MIPS program.

Review key elements of the MIPS program as it relates to scoring, including selecting the right measures and improvement activities that have the maximum scoring and bonus point potential.

Although recommendations regarding germline incidental findings exist, they are not specific for tumor testing. Clinical oncology panels have become larger and it is anticipated that this trend will continue with the possibility that tumor exomes may routinely be tested in the future.

In vivo microscopy (IVM) allows the microscopic evaluation of tissue without the tissue being excised. Potential applications of IVM include obtaining microscopic information from areas that are difficult to sample (for example, eye, brain, coronary arteries) and guiding biopsy locations in organs with lumens such that the sampled tissue is more likely to contain diagnostic tissue, while potentially decreasing the total number of biopsies needed to make a correct diagnosis.

This webinar offers a practical synopsis of the new lung cancer biomarker testing guidelines from two of the experts who wrote the guidelines: a pathologist and an oncologist.

While the discipline of surgical pathology remains the traditional “gold standard” for clinical tissue diagnoses, technological advances in biomedical optics and quantitative image analysis are rapidly emerging as complimentary diagnostic tools for pathologists.

This webinar will detail the newly released CAP guidelines on HPV testing for head and neck carcinomas, including a brief description of the evidence and rationale behind the major recommendations.

In this webinar, Drs. Seegmiller and Savona will discuss the emergence of molecular diagnostic testing, especially the use of multi-gene panels by next-generation sequencing, in myelodysplastic syndrome (MDS). They will describe the opportunities and limitations of these tests in diagnosis and prognosis of MDS, and their potential impact on the clinical care and treatment of patients with these diseases.

Traditional histopathology can be slow, expensive, and destructive, and it is not always available. Exciting new technologies such as MUSE (microscopy with UV-surface excitation) offer diagnostic-quality, full-color images from unsectioned tissue within minutes. Sample-preserving MUSE imaging of small, unfixed biopsy specimens can increase analyze yield vs. FFPE-processed samples, and facilitate quick and affordable precision medicine

With the American Joint Committee on Cancer (AJCC) release in 2016 of the AJCC Cancer Staging Manual, 8th edition, extensive modifications to the CAP cancer protocols are required to allow pathologists to report the new 8th edition staging starting January 1, 2018.

Physician burnout is reaching epidemic levels as increasing regulations and requirements result in more burdens on physicians and their practices.

The Food and Drug Administration (FDA) has approved the first whole slide imaging (WSI) system for primary diagnosis. What specific regulatory steps were included in the approval process? Why did it take years to complete? What exactly has been approved and what is the impact of this decision on the field of digital pathology for clinical use? Is it still necessary for individual institutions to conduct validation studies before implementation? What are the implications for laboratories that have systems other than the one-approved system?

This webinar will comprehensively discuss a systematic approach to the non-invasive management of inflammatory skin lesions such as psoriasiform, spongiotic and lichenoid.

Immuno Oncology therapies offer some of the most promising and effective options for cancer treatment, and are revolutionizing the way we think about oncology practice.

In the next few weeks, the Centers for Medicare & Medicaid Services' (CMS) will finalize the 2018 Medicare Physician Fee Schedule with changes to reimbursement rates for pathology services next year.

In this webinar, Dr. Reder discusses one approach, light-sheet microscopy. Light-sheet microscopy can rapidly image a thin 3D volume over a large lateral extent at a tissue surface, a useful feature for imaging the irregular cut surfaces of fresh clinical specimens.

Light-sheet microscopy offers unparalleled ability to efficiently visualize large structures in 3D with cellular detail.

This webinar will comprehensively discuss a systematic approach to the non-invasive diagnosis of non-melanocytic skin lesions. The lecture will begin with the definitions of commonly used terms, followed by an overview of the diagnostic criteria for confocal image analysis, and as always, we will conclude with the presentation and discussion of relevant clinical and confocal cases.

Recent national efforts, such as the Choosing Wisely campaign, have brought to light the fact that much of what we do in medicine is unnecessary. In pathology and laboratory medicine, common areas of resource overutilization include testing that has no demonstrable benefit, testing that is beneficial but used in an inefficient manner and testing that is performed in settings with perverse financial incentives.

A description of how to set up a Patient Blood Management in your hospital's Transfusion Service to make blood transfusions safer—and save the hospital money.

During this 60-minute webinar, attendees will learn about health policy basics and the importance of getting involved in CAP advocacy initiatives.

CAP experts will review the proposed Centers for Medicare & Medicaid Services (CMS) 2018 Medicare Physician Fee Schedule.

A merger and acquisition (M&A) event is often disruptive to a pathology practice, at all levels of professional, management, and financial activities. Having a roadmap to navigate the troubled waters of such an event is a critical item to keep in a practice toolbox.

The liquid biopsy is currently being utilized as a first line test in non-small cell lung cancer, especially when tissue biopsy is not an option or when there is insufficient material on tissue biopsy for standard of care molecular testing.

In this webinar, the presenters will describe the highly successful establishment of a pathology-engineering collaboration at the University of Washington.

The recent Institute of Medicine (IOM) report on diagnostic errors emphasizes the importance of communication and error disclosure in medicine.

This webinar will comprehensively discuss a systematic approach to the non-invasive diagnosis of pigmented skin lesions.

The release in 2016 of the American Joint Committee on Cancer (AJCC) 8th edition Cancer Staging System required extensive modifications to the CAP Cancer Protocols to allow pathologists to report the new 8th edition staging starting January 1, 2018.

Whether you are a seasoned Policy Meeting veteran or a first timer thinking about going to the CAP Policy Meeting, then this webinar is for you.

Molecular testing to enhance the response of colorectal cancers (CRC) to targeted and conventional therapies has been the center of many recent studies.

Are you looking for ways to reduce wasted time & resources? Do you need to do more with less? Are you concerned about making errors in the lab? Does your laboratory experience delays in testing that result in frustrated doctors, patients, and laboratory staff? Join us for a new webinar on Workflow Mapping the Preanalytic Testing Process and learn how to reduce waste and variability. In this webinar, we’ll discuss tools for workflow mapping, such as Lean, Six Sigma, and flow charting (process mapping). And we’ll describe how the 2017 Q-PROBES™ study Workflow Process Mapping can help you create a process map that can be compared to other laboratories’ maps, providing further insight into your preanalytic testing process.

With a new presidential administration, the US government will pursue policies that are yet hard to predict.

You've seen the checklist requirements for an Individual Quality Control Plan (IQCP), but may not be sure how to get started. This webinar will get you started and ensure compliance with accreditation requirements. An IQCP includes many practices that your laboratory already engages in to ensure quality testing, not just the frequency and number of QC materials.

The immune system plays a fundamental role in tumor biology, and the ability to avoid immune destruction has been recognized as an emerging hallmark of cancer.

Throughout this hour-long panel discussion, CAP experts will explain the changes by the Centers for Medicare & Medicaid Services (CMS) in the 2017 Medicare Physician Fee Schedule.

The microbiota, or compending of organisms living in us and on us, plays essential functions in our natural development, metabolism, immune function, and susceptibility to a variety of diseases.

Your payer contracts account for the vast majority of your practice's income. Learn how to assess seven critical areas that could impact your practice's financial future.

Do you really know the Unit Level Cost in your practice? Learn how to calculate this key metric for managing your bottom line.

Are your pathologists pulling the practice in a different direction? Does your practice know what is important to them? Learn what your practice should know and how to find out to move your practice forward.

Experts from the CAP’s Instrumentation Resource Committee have developed a free webinar that helps improve your understanding of calibration, calibration verification and analytical measurement range (AMR).

Human biospecimens are the starting materials for all anatomic pathology analyses, but the quality bar for specimens has been set by morphological standards, not molecular standards.